ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

FDA Discloses Avastin Regulatory History.

December 14, 2007

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991